Charles & Colvard Ltd. (CTHR) News
Filter CTHR News Items
CTHR News Results
Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
---|---|---|---|---|---|---|---|---|---|
Loading, please wait... |
Latest CTHR News From Around the Web
Below are the latest news stories about CHARLES & COLVARD LTD that investors may wish to consider to help them evaluate CTHR as an investment opportunity.
Charles & Colvard, Ltd. Receives Interim Award in Wolfspeed ArbitrationCharles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today announced that on December 5, 2024, it received an interim award in its confidential arbitration with Wolfspeed, Inc. Importantly, the award rejected Wolfspeed's claims to expectation damages of approximately $22.8 million, limiting the Company's damages to just $3.3 million representing approximately $1.3 million for inventory previously purchased and approximately $2.0 million of consigned inventory in the Comp |
Charles & Colvard, Ltd. Receives Non-Compliance Letter from NasdaqCharles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today announced that on November 21, 2024, it received a letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic reports (the "Listing Rule"), as a result of not having timely filed its Quarterly Report on Form 10-Q for the fiscal quarter |
Milestone Scientific Announces CEO Transition, with Chairman Neal Goldman Serving as Interim CEOROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its Chief Executive Officer Arjan Haverhals will retire from his role as an officer of the company on December 31, 2024. Upon his retirement, Mr. Haverhals will continue to serve as a director on the Board and will provide consulting services to ensure continuity and support throu |
Charles & Colvard, Ltd. Comments on a Letter from Riverstyx Capital Management to Charles & Colvard ShareholdersCharles & Colvard, Ltd. ("Charles & Colvard" or the "Company") (Nasdaq: CTHR) today commented on a letter sent to the Company's shareholders and released publicly by Riverstyx Capital Management, LLC ("Riverstyx"). The Company provided the following statement in response: |
Zacks Initiates Coverage of Charles & Colvard With Underperform RecommendationDiscover why Zacks has rated Charles & Colvard as "Underperform," being the first on Wall Street to initiate coverage on the stock. Explore the significant challenges posed by declining sales, shrinking margins, rising expenses, fierce competition and liquidity concerns, despite strategic efforts. |
CHARLES & COLVARD REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE LISTING REQUIREMENTCharles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, announced today that it has regained compliance with Nasdaq's minimum bid price continued listing requirement. A letter from Nasdaq Listing Qualifications Department noted that as of May 31, 2024, the minimum bid price of the Company's common stock was $1.00 per share or greater for the last 10 consecutive business/trading days. As a result, th |
Charles & Colvard Allies With International Gemological Institute on Grading Moissanite StonesCharles & Colvard's CEO says collaborating with IGI will maintain brand integrity in a market saturated with false information and counterfeits. |
CHARLES & COLVARD FORGES EXCLUSIVE STRATEGIC ALLIANCE WITH IGI TO SUPPLY MOISSANITE GRADING REPORTSCharles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, is pleased to announce an exclusive strategic alliance with the International Gemological Institute (IGI), introducing comprehensive grading reports for moissanite gemstones and jewelry. |
CHARLES & COLVARD ANNOUNCES REVERSE STOCK SPLITCharles & Colvard, Ltd. (Nasdaq: CTHR) (the "Company"), a globally recognized fine jewelry company that specializes in moissanite and lab grown diamonds, announced today that the Company's Board of Directors has approved a one-for-ten (1:10) reverse split of the Company's common stock, no par value per share (the "Reverse Stock Split"), to be effective as of 12:01 a.m. Eastern Time on May 17, 2024 (the "Effective Date"). The Reverse Stock Split is intended to bring the Company into compliance wi |
Several Insiders Invested In Charles & Colvard Flagging Positive NewsUsually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like... |